TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Inscripta Stock

Inscripta Stock

inscripta.comHealthcareFounded: 2015Funding to Date: $459.69MM

Inscripta is the developer of a benchtop platform for scalable digital genome engineering consisting of an instrument, consumables, software, and assays, that offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale.

Buy or sell Inscripta stockLearn more about Inscripta IPO
Register for Details

For more details on financing and valuation for Inscripta, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Inscripta.

Register Today

Inscripta investors also invested in these private companies

Venrock
D1 Capital Partners
Durable Capital Partners
Paladin Capital Group
Foresite Capital

Team

Management Team

Michael Graige Ph.D
Chief Technology Officer
Andrew Garst Ph.D
Co-Founder & Principal Scientist
Kevin Ness Ph.D
Chief Executive Officer
Jason Gammack
Chief Commercial Officer

Board Members

Bryan Roberts Ph.D
Venrock
Roger Wyse Ph.D
Spruce Capital Partners
Eric Moessinger
NanoDimension
John Stuelpnagel

Other companies like Inscripta in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Paradromics
Sector
Healthcare
 
 
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B

News

Business Wire 01/10/2022
Ginkgo Bioworks Adopts Inscripta’s Onyx Digital Genome Engineering Platform to Continue Accelerating its Genome Editing Throughput
Inscripta, the digital genome engineering company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, has adopted the Onyx™ genome engineering platform in its foundries.
EU Startups 05/31/2021
Finnish startup Inscripta raises €700K to grow its speech recognition technology | EU-Startups
The Finnish language technology company Inscripta Oy has raised a total of 700K in funding for the further development of its self-developed speech recognition technology and final solutions. Having begun operations in 2016, Inscripta is a 16-person software company that has developed a comprehensive and versatile end-to-end speech recognition solution for healthcare organizations and other […]
FINSMES 04/05/2021
Inscripta Closes $150M Series E Financing | FinSMEs
Inscripta, Inc., a Boulder, CO-based digital genome engineering company, closed a $150m Series E financing

Trending Companies

Frequently Asked Questions

Updated on: Jun 1, 2023